γ-sarcoglycan Antibody (E-8): sc-515628

γ-sarcoglycan Antibody (E-8) is a mouse monoclonal IgG1 kappa light chain antibody that detects gamma-sarcoglycan of human origin by western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), and enzyme-linked immunosorbent assay (ELISA). Anti-gamma-sarcoglycan antibody (E-8) is available in both non-conjugated and various conjugated forms, including agarose, horseradish peroxidase (HRP), phycoerythrin (PE), fluorescein isothiocyanate (FITC), and multiple Alexa Fluor® conjugates. Gamma-sarcoglycan plays a crucial role in the dystrophin-glycoprotein complex, which maintains the structural integrity of muscle cell membranes. Gamma-sarcoglycan is primarily located in the cell membrane of skeletal, cardiac, and smooth muscle fibers, where gamma-sarcoglycan interacts with other sarcoglycan subunits—α-, β-, and δ-sarcoglycan—to form a stable complex that protects muscle cells from damage during contraction. A deficiency or mutation in any sarcoglycan proteins can lead to complex destabilization, resulting in conditions such as sarcoglycanopathy, a form of autosomal recessive muscular dystrophy. In smooth muscle, β- and δ-sarcoglycans interact with ε-sarcoglycan, a glycoprotein homologous to α-sarcoglycan, highlighting gamma-sarcoglycan′s importance in muscle function and pathology. A complete deficiency in δ-sarcoglycan has been linked to cardiomyopathy development in the Syrian hamster BIO.14 model, underscoring gamma-sarcoglycan′s significance in muscle health and disease.

Alexa Fluor^® is a trademark of Molecular Probes Inc., OR., USA

LI-COR^® and Odyssey^® are registered trademarks of LI-COR Biosciences

γ-sarcoglycan Antibody (E-8) References:

1. Differential requirement for individual sarcoglycans and dystrophin in the assembly and function of the dystrophin-glycoprotein complex.  |  Hack, AA., et al. 2000. J Cell Sci. 113 (Pt 14): 2535-44. PMID: 10862711
2. Expression of gamma -sarcoglycan in smooth muscle and its interaction with the smooth muscle sarcoglycan-sarcospan complex.  |  Barresi, R., et al. 2000. J Biol Chem. 275: 38554-60. PMID: 10993904
3. Cellular and molecular properties of alpha-dystrobrevin in skeletal muscle.  |  Enigk, RE. and Maimone, MM. 2001. Front Biosci. 6: D53-64. PMID: 11145920
4. Identification of myogenesis-dependent transcriptional enhancers in promoter region of mouse gamma-sarcoglycan gene.  |  Wakabayashi-Takai, E., et al. 2001. Eur J Biochem. 268: 948-57. PMID: 11179961
5. Evaluation of cardiac and respiratory involvement in sarcoglycanopathies.  |  Politano, L., et al. 2001. Neuromuscul Disord. 11: 178-85. PMID: 11257475
6. delta- and gamma-Sarcoglycan localization in the sarcoplasmic reticulum of skeletal muscle.  |  Ueda, H., et al. 2001. J Histochem Cytochem. 49: 529-38. PMID: 11259456
7. Transplanted hematopoietic stem cells demonstrate impaired sarcoglycan expression after engraftment into cardiac and skeletal muscle.  |  Lapidos, KA., et al. 2004. J Clin Invest. 114: 1577-85. PMID: 15578090
8. Sarcoglycan and integrin localization in normal human skeletal muscle: a confocal laser scanning microscope study.  |  Anastasi, G., et al. 2004. Eur J Histochem. 48: 245-52. PMID: 15590414
9. Administration of insulin-like growth factor-1 (IGF-1) improves both structure and function of delta-sarcoglycan deficient cardiac muscle in the hamster.  |  Serose, A., et al. 2005. Basic Res Cardiol. 100: 161-70. PMID: 15611844
10. Epsilon-sarcoglycan immunoreactivity and mRNA expression in mouse brain.  |  Chan, P., et al. 2005. J Comp Neurol. 482: 50-73. PMID: 15612018
11. gamma-Sarcoglycan deficiency increases cell contractility, apoptosis and MAPK pathway activation but does not affect adhesion.  |  Griffin, MA., et al. 2005. J Cell Sci. 118: 1405-16. PMID: 15769854
12. Mild and severe muscular dystrophy caused by a single gamma-sarcoglycan mutation.  |  McNally, EM., et al. 1996. Am J Hum Genet. 59: 1040-7. PMID: 8900232

Monoclonal antibodies for mammalian and non-mammalian protein targets represent essentially all targets covered by polyclonal antibodies. Over 8,300 of our antibodies are offered as ImmunoCruz^® conjugates which eliminates the need for a secondary antibody.

Santa Cruz Biotechnology antibodies have over 360,000 research citations. Anti-γ-sarcoglycan Antibody (E-8) has 1 citations in a variety of scientific publications.

Primary antibodies like Anti-γ-sarcoglycan Antibody (E-8) for mammalian target proteins are recommended for the detection of a range of mammalian species, primarily of mouse, rat and human species. Many mammalian antibodies are also ideal for veterinary research and reactive with ovine, porcine, caprine, feline, canine, bovine and equine protein targets. Santa Cruz Biotechnology primary monoclonal antibodies are suitable for laboratory research applications and are not intended for diagnostic or therapeutic use.

γ-sarcoglycan Antibody (E-8) Specifications

Alternate Product Name: γ-sarcoglycan

Product Clone Name: E-8

Classification: Primary Antibody

Clonality: Monoclonal Antibody

Antibody Isotype: IgG₁ kappa light chain

Amino Acids: 221-246

Epitope Target: γ-Sarcoglycan

Epitope Species: human

Product Reactivity/Detection: γ-sarcoglycan

Species Reactivity/Detection: human

Additional Mammalian Reactivity: N/A

Additional Non-Mammalian Reactivity: N/A

Applications: WB, IP, IF, ELISA

Vialing Information: Each vial contains 200 µg IgG₁ kappa light chain in 1.0 ml of PBS with < 0.1% sodium azide and 0.1% gelatin

Research Citations: 1 citations in various scientific publications

Available Conjugates/Forms for γ-sarcoglycan Antibody (E-8): AC: Agarose, AF488: Alexa Fluor^® 488, AF546: Alexa Fluor^® 546, AF594: Alexa Fluor^® 594, AF647: Alexa Fluor^® 647, AF680: Alexa Fluor^® 680, AF790: Alexa Fluor^® 790, FITC: Fluoroscein, HRP: Horseradish Peroxidase, P: Blocking Peptide, PE: Phycoerythrin